Ashik Pavagadhi of IDT Biologika explains the company’s push to expand in the U.S. market and how ongoing investment in best-in-class technology and a commitment to adapt to meet the changing needs of the industry has led to this unique milestone and will drive IDT’s second century, as part of Pharma's Almanac's Road to 50 States campaign.
.svg)
